Our Mission
Early Detection for Life-Saving interventions
We are committed to providing reliable, accessible and high-quality assays for newborn screening for SCID, SMA, and XLA, improving the quality of life of babies and their parents.
Our assays are recognized for their reliability and easy-to-use workflow, that requires minimal laboratory space and equipment investment.
Focused expertise in SCID, SMA and XLA Screening – rooted in research, shaped by customer insights.
Discover ImmunoIVD
Newborns screened with SPOT-it™ kits each year
Years in business
Years of expertise in providing SCID screening assays
CE IVD
marked assays
Products
An in vitro diagnostic (IVD) kit intended for newborn screening for severe combined immunodeficiency (SCID).
Learn More
An in vitro diagnostic (IVD) kit intended for newborn screening for severe combined immunodeficiency (SCID) and agammaglobulinemia (XLA).
Learn More
An in vitro diagnostic (IVD) kit intended for newborn screening for severe combined immunodeficiency (SCID) and spinal muscular atrophy (SMA) in newborns.
Learn More
An in vitro diagnostic (IVD) kit intended for newborn screening for severe combined immunodeficiency (SCID), agammaglobulinemia (XLA), and spinal muscular atrophy (SMA) in newborns.
Learn MoreSPOT-it™ Screening Solutions
SPOT-it™ Screening Solutions
Designed for routine screening labs
- Swedish design for quick and easy procedure — no liquid-handling equipment needed.
- Minimized hands-on time thanks to pre-filled and ready-to-use reagent plates.
- The use of pre-filled reagent plates eliminates the need for a separate clean room for MasterMix preparation.
Reliable and sensitive qPCR-based assays
- From Dried Blood Spot to screening result within three hours.
- Market-leading provider of SCID newborn screening assays in Europe.
- Used in national screening programs in multiple European countries since 2017.
Our Expertise
Applications
Designed for routine screening
Our SPOT-it™ kits eliminate the need for costly automation equipment or separate clean room, thanks to our innovative plate-stacking technology and pre-filled reagent plates.
Erna Domsgen
Chief Executive Officer at ImmunoIVD, PhD in Molecular Biology
Play company video now
Interested in reliable CE marked products?
Let us present our newborn screening kits
Meet us and talk.
Follow us on LinkedIn
October 9, 2024
We are committed to Environmental Sustainability
We are now ISO14001 certified. ImmunoIVD awarded A+ score on the environmental, social, and governance (ESG) rating, as evaluated by one of our customers.
August 28, 2024
CHU Grenoble Alpes receives training in the use of SPOT-it™ assay for SCID and SMA newborn screening.
The laboratory is now ready to accommodate other French laboratories who want hands-on experience with the SPOT-it™ Screening Kit.
October 19, 2024
We are exhibiting at a series of key industry events
Meet us in Ljubljana, Marseille, New York, and Omaha. Let’s meet and explore new opportunities together.